SynteractHCR, GOG sign 3-year agreement to leverage services

By Melissa Fassbender

- Last updated on GMT

SynteractHCR is a full-service, international contract research organization. (Image: iStock/Jirsak)
SynteractHCR is a full-service, international contract research organization. (Image: iStock/Jirsak)
The international contract research organization (CRO) and non-profit organization have signed a three-year “teaming agreement” to advance clinical trials for gynecologic malignancies.

The GOG Foundation, Inc. (GOG) works with biopharmaceutical drug developers researching therapies in gynecologic cancer indications and features a network of more than 300 investigational institutions in Japan, Korea, Australia, and the US.

As part of the agreement, GOG will recommend SynteractHCR as its preferred CRO to assist its clients with their clinical trial needs.

Conversely, SynteractHCR will recommend GOG to its current and potential customers – providing sponsors access to the non-profit’s network in order to accelerate investigator selection and patient recruitment.

Wendel Barr, CEO of SynteractHCR told us the agreement with GOG combines the companies experience in drug development in oncology and gynecology.

In aligning with GOG, we are collaborating with an organization with the same dedicated focus to bringing treatments forward in areas of greatest need, and doing so in a more targeted, precise and efficient fashion to benefit our sponsors​,” Barr added.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars